Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome.

Journal of Medical Genetics (Impact Factor: 5.64). 11/2006; 43(10):822-8. DOI: 10.1136/jmg.2005.038604
Source: PubMed

ABSTRACT The 22q13.3 deletion syndrome (MIM 606232) is characterised by neonatal hypotonia, normal to accelerated growth, absent to severely delayed speech, global developmental delay, and minor dysmorphic facial features. We report the molecular characterisation of the deletion breakpoint in two unrelated chromosome 22q13.3 deletion cases.
The deletions were characterised by FISH, checked for other abnormalities by array-CGH, and confirmed by Real-Time PCR, and finally the breakpoints were cloned, sequenced, and compared.
Both cases show the cardinal features of the 22q13.3 deletion syndrome associated with a deletion involving the last 100 kb of chromosome 22q13.3. The cases show a breakpoint within the same 15 bp repeat unit, overlapping the results obtained by Wong and colleagues in 1997 and suggesting that a recurrent deletion breakpoint exists within the SHANK3 gene. The direct repeat involved in these 22q13 deletion cases is presumably able to form slipped (hairpin) structures, but it also has a strong potential for forming tetraplex structures.
Three cases with a common breakpoint within SHANK3 share a number of common phenotypic features, such as mental retardation and developmental delay with severely delayed or absent expressive speech. The two cases presented here, having a deletion partially overlapping the commercial subtelomeric probe, highlight the difficulties in interpreting FISH results and suggest that many similar cases may be overlooked.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Copy number variations (CNVs) are an important cause of ASD and those located at 15q11-q13, 16p11.2 and 22q13 have been reported as the most frequent. These CNVs exhibit variable clinical expressivity and those at 15q11-q13 and 16p11.2 also show incomplete penetrance. In the present work, through multiplex ligation-dependent probe amplification (MLPA) analysis of 531 ethnically admixed ASD-affected Brazilian individuals, we found that the combined prevalence of the 15q11-q13, 16p11.2 and 22q13 CNVs is 2.1% (11/531). Parental origin could be determined in 8 of the affected individuals, and revealed that 4 of the CNVs represent de novo events. Based on CNV prediction analysis from genome-wide SNP arrays, the size of those CNVs ranged from 206 kb to 2.27 Mb and those at 15q11-q13 were limited to the 15q13.3 region. In addition, this analysis also revealed 6 additional CNVs in 5 out of 11 affected individuals. Finally, we observed that the combined prevalence of CNVs at 15q13.3 and 22q13 in ASD-affected individuals with epilepsy (6.4%) was higher than that in ASD-affected individuals without epilepsy (1.3%; p<0.014). Therefore, our data show that the prevalence of CNVs at 15q13.3, 16p11.2 and 22q13 in Brazilian ASD-affected individuals is comparable to that estimated for ASD-affected individuals of pure or predominant European ancestry. Also, it suggests that the likelihood of a greater number of positive MLPA results might be found for the 15q13.3 and 22q13 regions by prioritizing ASD-affected individuals with epilepsy.
    PLoS ONE 09/2014; 9(9):e107705. · 3.53 Impact Factor
  • Source
    Medicine in Evolution 2065-376X. 01/2012; XVIII(4):572 - 577.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La citogenética molecular es una poderosa herramienta en el diagnóstico e investigaciones actuales, donde la hibridación in situ con fluorescencia (FISH) es uno de sus puntales. De acuerdo al diagnóstico o investigación a realizar se selecciona el tipo de sonda a utilizar; así, tenemos que las sondas genes-específicas son útiles en la detección de enfermedades en las que se conoce la secuencia génica afectada; las sondas de secuencias repetitivas son utilizadas en la detección de aneuploidías y estudios de retraso mental. Otra variante como el CGH (Comparative Genomic Hybridisation), es una nueva tecnología donde se compara el ADN tumoral y ADN normal, marcados con fluorocromos diferentes, permitiendo detectar ganancias o pérdidas en el ADN del tumor y hacer predicciones de su evolución y posible tratamiento. Por otro lado, el SKY permite detectar translocaciones crípticas al colorear cada cromosoma con un color diferente y el Rx-FISH nos permite detectar aberraciones intracromosómicas, además de identificar anillos y cromosomas marcadores. Molecular cytogenetics is recognized as a powerful tool for diagnosis and research in cytogenetics, while Fluorescent in situ Hybridization (FISH) is considered one of its central pillars. Probes are selected after making the decision of whether to conduct a diagnostic or a research activity; DNA probes (gene-specific) are used to locate a particular portion of a DNA molecule of any disease in which the affected gene sequence is known. In the detection of aneuploidy and mental retardation, repeated sequence probes are used Another technology is Comparative Genomic hybridization (CGH) which consists of a molecular-cytogenetic method for the analysis of copy number changes (gains/losses) in the DNA content of tumor cells. This method is based on the hybridization of fluorescently labeled tumor (frequently Fluorescein -FITC) and normal DNA (frequently Rhodamine or Texas Red) to normal human metaphase preparations. Finally, SKY methodology allows criptic tranlocations to be detected, because it labels and identifies each human chromosome pair by a different fluorescent color, using combinatorial labelling. Rx–FISH is useful to detect intra chromosomic aberrations and to identify rings and marker chromosomes.
    Revista Cubana De Genetica Comunitaria. 09/2014; 1(2):9-14.

Full-text (2 Sources)

Available from
May 21, 2014